After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...
Starting today, people with Parkinson's disease will have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology.
The FDA’s authorisation of Medtronic’s BrainSense follows the system’s receipt of a CE mark in Europe last month.
Working memory is what allows humans to juggle different pieces of information in short-term scenarios, like making a mental grocery list and then going shopping or remembering and then dialing a ...
New research shows people in specific Polynesian communities have a much higher rate of a form of Parkinson’s disease ...
There is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...
The closed-loop system dynamically self-adjusts DBS therapy to individual brain activity in real time, providing personalized ...
The BrainSense Adaptive technology is an enhancement to Medtronic’s Percept DBS neurostimulators. The advancement personalizes therapy based on a patient’s brain activity in real-time. Therapy ...
New findings from scientists from the Carney Institute for Brian Science explain memory limits and shed light on ...
The company's adaptive deep brain stimulation technology for Parkinson's disease therapy is expected to be available nationwide in the next few months.
Medtronic said the Food and Drug Administration approved a brain stimulation system for people afflicted with Parkinson's disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results